What is Ewing's classification of the family Enterobacteriaceae?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ewing's Classification of Family Enterobacteriaceae is a foundational system in clinical microbiology that organizes gram-negative bacteria into tribes based on biochemical properties and antigenic structures, which is crucial for identifying the causative agents of infections and guiding appropriate antibiotic therapy. The classification system divides Enterobacteriaceae into five main tribes: Escherichieae (including Escherichia coli), Klebsielleae (including Klebsiella and Enterobacter), Proteeae (including Proteus and Morganella), Salmonelleae (including Salmonella), and Yersinieae (including Yersinia) 1. Some key points about this classification system include:

  • It helps microbiologists and clinicians identify and categorize these important pathogens based on their fermentation patterns, motility, and other biochemical characteristics.
  • The system is particularly useful in clinical settings for identifying the causative agents of infections, which guides appropriate antibiotic therapy.
  • Knowing that an infection is caused by a member of a specific tribe might suggest inherent resistance to certain antibiotics, as seen with the Proteeae tribe.
  • Newer molecular classification methods, such as the Ambler classification system for carbapenemases, have supplemented Ewing's system, highlighting the importance of understanding the molecular mechanisms of resistance in guiding treatment strategies 1. Key aspects of the Ambler classification system include:
  • Class A (K. pneumoniae carbapenemase, KPC)
  • Class B (metallo-β-lactamases, MBLs: NDM, VIM, IMP)
  • Class D (OXA-48-like) These classes confer variable susceptibility profiles that require different treatment strategies, emphasizing the need for rapid testing to identify specific carbapenemases and guide antibiotic therapy 1.

From the Research

Ewing's Classification of Family Enterobacteriaceae

There are no research papers to assist in answering this question, as the provided studies do not mention Ewing's Classification of Family Enterobacteriaceae.

Overview of Enterobacteriaceae

  • Enterobacteriaceae are a large family of Gram-negative, non-spore-forming bacteria 2
  • They include common nosocomial pathogens such as Klebsiella pneumoniae, Escherichia coli, Serratia marcescens, and Enterobacter species 3
  • Some members of this family are associated with both intestinal and extraintestinal diseases 2

Antibiotic Resistance in Enterobacteriaceae

  • Resistance to antibiotics, especially β-lactam type, is increasingly dominated by the mobilization of continuously expressed single genes that encode efficient drug-modifying enzymes 4
  • The emergence and spread of resistance in Enterobacteriaceae are complicating the treatment of serious nosocomial infections and threatening to create species resistant to all currently available agents 5, 6
  • ESBL-producing Enterobacteriaceae have now emerged in the community as well, and are often associated with multidrug resistance 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Enterobacteria and host resistance to infection.

Mammalian genome : official journal of the International Mammalian Genome Society, 2018

Research

Resistance in gram-negative bacteria: Enterobacteriaceae.

American journal of infection control, 2006

Research

Resistance in gram-negative bacteria: enterobacteriaceae.

The American journal of medicine, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.